Literature DB >> 17241702

Early disruptions of the blood-brain barrier may contribute to exacerbated neuronal damage and prolonged functional recovery following stroke in aged rats.

Vincent A DiNapoli1, Jason D Huber, Kimberly Houser, Xinlan Li, Charles L Rosen.   

Abstract

We examined the effects of age on stroke progression and outcome in order to explore the association between blood-brain barrier (BBB) disruption, neuronal damage, and functional recovery. Using middle cerebral artery occlusion (MCAO), young (3 months) and aged (18 months) rats were assessed for BBB disruption at 20min post-MCAO, and 24h post-MCAO with tissue plasminogen activator induced reperfusion at 120min. Results showed that BBB disruptions in aged rats occurred early and increased nearly two-fold at both the 20min and 24h time points when compared to young animals. Neuronal damage in aged rats was increased two-fold as compared to young rats at 24h, while no neuronal damage was observed at 20min. Young and aged rats exhibited neurological deficits when compared to sham-controls out to 14 days following MCAO and reperfusion; however, aged rats exhibited more severe onset of deficits and prolonged recovery. Results indicate that aged rats suffer larger infarctions, reduced functional recovery and increased BBB disruption preceding observable neuronal injury.

Entities:  

Mesh:

Year:  2007        PMID: 17241702      PMCID: PMC2683361          DOI: 10.1016/j.neurobiolaging.2006.12.007

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  40 in total

1.  Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke.

Authors:  L D McCullough; N J Alkayed; R J Traystman; M J Williams; P D Hurn
Journal:  Stroke       Date:  2001-03       Impact factor: 7.914

2.  Testosterone increases neurotoxicity of glutamate in vitro and ischemia-reperfusion injury in an animal model.

Authors:  Shao-Hua Yang; Evelyn Perez; Jason Cutright; Ran Liu; Zhen He; Arthur L Day; James W Simpkins
Journal:  J Appl Physiol (1985)       Date:  2002-01

3.  Effect of age in rats following middle cerebral artery occlusion.

Authors:  Ray-Yua Wang; Paulus Shyi-Gang Wang; Yea-Ru Yang
Journal:  Gerontology       Date:  2003 Jan-Feb       Impact factor: 5.140

4.  Temporary and permanent focal cerebral ischemia in the mouse: assessment of cerebral blood flow, brain damage and blood-brain barrier permeability.

Authors:  Y Mao; G Yang; L Zhou
Journal:  Chin Med J (Engl)       Date:  2000-04       Impact factor: 2.628

5.  Apoptosis and activation of Erkl/2 and Akt in astrocytes postischemia.

Authors:  Zhongjian Jiang; Yun Zhang; Xiao Qian Chen; Philip Yeung Lam; Hui Yang; Qunyuan Xu; Albert Cheung Hoi Yu
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

6.  Aromatase cytochrome P450 and extragonadal estrogen play a role in ischemic neuroprotection.

Authors:  Louise D McCullough; Kathleen Blizzard; Evan R Simpson; Orhan K Oz; Patricia D Hurn
Journal:  J Neurosci       Date:  2003-09-24       Impact factor: 6.167

7.  Selective MCA occlusion: a precise embolic stroke model.

Authors:  Vincent A Dinapoli; Charles L Rosen; Tomoaki Nagamine; Todd Crocco
Journal:  J Neurosci Methods       Date:  2006-02-10       Impact factor: 2.390

8.  Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions.

Authors:  Jasmina B Mackic; James Bading; Jorge Ghiso; Larry Walker; Thomas Wisniewski; Blas Frangione; Berislav V Zlokovic
Journal:  Vascul Pharmacol       Date:  2002-06       Impact factor: 5.773

Review 9.  Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions.

Authors:  David J Gladstone; Sandra E Black; Antoine M Hakim
Journal:  Stroke       Date:  2002-08       Impact factor: 7.914

Review 10.  New perspectives on developing acute stroke therapy.

Authors:  Marc Fisher; Rajiv Ratan
Journal:  Ann Neurol       Date:  2003-01       Impact factor: 10.422

View more
  77 in total

Review 1.  Targeting the neurovascular unit for treatment of neurological disorders.

Authors:  Reyna L Vangilder; Charles L Rosen; Taura L Barr; Jason D Huber
Journal:  Pharmacol Ther       Date:  2010-12-21       Impact factor: 12.310

Review 2.  The blood-brain barrier: geriatric relevance of a critical brain-body interface.

Authors:  Neer Zeevi; Joel Pachter; Louise D McCullough; Leslie Wolfson; George A Kuchel
Journal:  J Am Geriatr Soc       Date:  2010-09       Impact factor: 5.562

3.  Differential effects of aging and sex on stroke induced inflammation across the lifespan.

Authors:  Bharti Manwani; Fudong Liu; Victoria Scranton; Matthew D Hammond; Lauren H Sansing; Louise D McCullough
Journal:  Exp Neurol       Date:  2013-08-29       Impact factor: 5.330

Review 4.  What Do Experimental Models Teach Us About Comorbidities in Stroke?

Authors:  Sunghee Cho; Jiwon Yang
Journal:  Stroke       Date:  2018-01-08       Impact factor: 7.914

5.  Functional recovery in aging mice after experimental stroke.

Authors:  Bharti Manwani; Fudong Liu; Yan Xu; Rebecca Persky; Jun Li; Louise D McCullough
Journal:  Brain Behav Immun       Date:  2011-07-02       Impact factor: 7.217

Review 6.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

7.  Perlecan domain V is neuroprotective and affords functional improvement in a photothrombotic stroke model in young and aged mice.

Authors:  Gregory J Bix; Emma K Gowing; Andrew N Clarkson
Journal:  Transl Stroke Res       Date:  2013-06-07       Impact factor: 6.829

8.  Combination treatment of r-tPA and an optimized human apyrase reduces mortality rate and hemorrhagic transformation 6h after ischemic stroke in aged female rats.

Authors:  Zhenjun Tan; Xinlan Li; Ryan C Turner; Aric F Logsdon; Brandon Lucke-Wold; Kenneth DiPasquale; Soon Soeg Jeong; Ridong Chen; Jason D Huber; Charles L Rosen
Journal:  Eur J Pharmacol       Date:  2014-06-13       Impact factor: 4.432

9.  Insulin-like Growth Factor (IGF)-1 treatment stabilizes the microvascular cytoskeleton under ischemic conditions.

Authors:  Shameena Bake; Andre Okoreeh; Homa Khosravian; Farida Sohrabji
Journal:  Exp Neurol       Date:  2018-10-01       Impact factor: 5.330

10.  Endothelin-1-induced focal cerebral ischemia in the growth hormone/IGF-1 deficient Lewis Dwarf rat.

Authors:  Han Yan; Matthew Mitschelen; Peter Toth; Nicole M Ashpole; Julie A Farley; Erik L Hodges; Junie P Warrington; Song Han; Kar-Ming Fung; Anna Csiszar; Zoltan Ungvari; William E Sonntag
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-08-06       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.